TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Open Orphan Plc ( (GB:HVO) ) has shared an announcement.
hVIVO plc has announced positive data from its novel human challenge models presented at key industry conferences in 2025. The company showcased its advancements in human challenge models for hMPV, SARS-CoV-2 Omicron, and RSV B, highlighting their safety, efficacy, and readiness for vaccine and antiviral trials. These developments reinforce hVIVO’s leadership in the field and its commitment to accelerating vaccine and therapeutic development, meeting the evolving needs of the industry.
The most recent analyst rating on (GB:HVO) stock is a Hold with a £7.50 price target. To see the full list of analyst forecasts on Open Orphan Plc stock, see the GB:HVO Stock Forecast page.
Spark’s Take on GB:HVO Stock
According to Spark, TipRanks’ AI Analyst, GB:HVO is a Neutral.
Open Orphan Plc’s stock score is primarily driven by its strong financial performance and attractive valuation. However, the weak technical indicators suggest caution. The company’s low P/E ratio and solid dividend yield are significant positives, but bearish market momentum and oversold conditions highlight potential risks.
To see Spark’s full report on GB:HVO stock, click here.
More about Open Orphan Plc
hVIVO plc is a leading early phase Contract Research Organisation (CRO) specializing in human challenge trials. The company provides comprehensive clinical development services, including virology and immunology laboratory services, through its hLAB brand. With facilities in London and Germany, hVIVO offers a range of services from preclinical stages to Phase II trials, supporting major biopharma companies globally.
Average Trading Volume: 1,998,023
Technical Sentiment Signal: Sell
Current Market Cap: £43.97M
For a thorough assessment of HVO stock, go to TipRanks’ Stock Analysis page.